XML 14 R4.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2024
Mar. 31, 2023
Sales:        
Total sales $ 13,706 $ 13,269 $ 29,081 $ 31,613
Cost of sales:        
Total cost of sales 7,228 8,279 18,508 20,806
Gross profit 6,478 4,990 10,573 10,807
Operating expenses:        
Engineering and development 726 858 1,426 1,694
Selling, general and administrative 4,518 3,895 8,256 7,512
Total operating expenses 5,244 4,753 9,682 9,206
Operating income 1,234 237 891 1,601
Other income (expense):        
Foreign exchange gain (loss) 32 (115) (142) (616)
Interest expense (46) (62) (95) (126)
Interest income 478 325 974 586
Other income, net 25 7 35 41
Total other income (expense), net 489 155 772 (115)
Income before income taxes 1,723 392 1,663 1,486
Income tax expense 135 71 148 204
Net income 1,588 321 1,515 1,282
Net income attributable to common shareholders $ 1,482 $ 302 $ 1,417 $ 1,205
Net income per common share - basic $ 0.16 $ 0.03 $ 0.16 $ 0.14
Net income per common share - diluted $ 0.16 $ 0.03 $ 0.15 $ 0.14
Weighted average common shares outstanding - basic 9,070 8,782 8,967 8,683
Weighted average common shares outstanding - diluted 9,455 8,924 9,366 8,789
Product        
Sales:        
Total sales $ 8,458 $ 8,988 $ 19,865 $ 23,209
Cost of sales:        
Total cost of sales 5,416 6,580 14,644 17,351
Service        
Sales:        
Total sales 5,248 4,281 9,216 8,404
Cost of sales:        
Total cost of sales $ 1,812 $ 1,699 $ 3,864 $ 3,455